Early Access — free while we kick the tires
EdgarHawk

ABALLI JOHN

President and CEO

Director Officer
1 filing analyzed · 1 company · Latest 2024-11-18

Companies

Company Buys Sells Direction
EXAGEN INC. XGN 1 0 Net buying

Activity

November 2024
2024-11-18 EXAGEN INC. XGN
medium
Buy
24,305 shares
$68,297
Significance 6/10

CEO Aballi buys 24,305 shares of XGN at $2.81, raising stake to 689.8K shares as company pursues growth amid profitability challenges.

President and CEO John Aballi purchased 24,305 shares at $2.81 on 2024-11-14, increasing his holdings from 665.5K to 689.8K shares (+3.7%). The transaction occurred at a price 6.3% below the current $3.00 level and well below the 52-week high of $3.42. Aballi's prior purchase at this same ticker on 2024-05-16 delivered 90-day returns of +49.0%, establishing a demonstrated pattern of well-timed entry timing. The company is growing revenues at +15.3% annually but remains unprofitable, with latest quarterly net income of $-5.0M against $12.5M in revenue, creating a mixed signal: management's share accumulation suggests confidence in turnaround prospects, yet the company's current cash burn and market cap of $52.9M warrant investor scrutiny of whether execution can bridge to profitability.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access